COMMUNIQUÉS West-GlobeNewswire

Curia publie son rapport ESG (environnement, social et gouvernance) 2024
29/10/2025
ALBANY, New York, 29 oct. 2025 (GLOBE NEWSWIRE) -- Curia Global, Inc. (Curia), l’une des principales organisations de recherche, de développement et de fabrication sous contrat, a annoncé aujourd’hui la publication de [...]
Neutrolis Presented First-in-Human Proof-of-Concept Data Validating DNASE1L3-Mediated Neutrophil Extracellular Trap (NET) Clearance as a Therapeutic Approach in Autoimmunity at American College of Rheumatology Convergence 2025
29/10/2025
- First-in-human data validating direct targeting of NETs as a novel therapeutic approach in autoimmunity and inflammatory diseases - DNASE1L3 analogue therapy degrades NETs and results in rapid, multi-organ clinical [...]
Virginia Cannabis Dispensary Cannisco Unveils New Brand Identity as East Coast Collective Transitions
29/10/2025
Shenandoah Valley-Based Hemp Company Rebrands to Reflect Commitment to Quality, Integrity, and Seed-to-Sale Excellence Shenandoah Valley, Virginia, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Cannisco , formerly East Coast [...]
Telitacicept Demonstrates Sustained Efficacy and Favorable Safety Profile in 48-Week China Phase 3 Open-Label Extension Generalized Myasthenia Gravis Data
29/10/2025
Telitacicept delivered consistent quality-of-life improvement across both treatment and placebo crossover arms 100% of patients on telitacicept for 48 weeks achieved ≥2-point Myasthenia Gravis Activities of Daily Living [...]
argenx Presents New Data at AANEM and MGFA Highlighting the Strength and Broad Benefit of VYVGART for Myasthenia Gravis Patients
29/10/2025
VYVGART demonstrated clinically meaningful benefit across all AChR-Ab seronegative gMG subtypes in ADAPT SERON, supporting broad role of pathogenic IgGs in disease activity Final ADAPT SC+ results show ~60% of VYVGART [...]
Plum Tree Launches New Chronic Illness Therapy Program
29/10/2025
ST. CHARLES, Ill., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Plum Tree Psychology, Ltd., a leading child and family mental health practice in the Fox Valley, today announced the launch of Hoot & Holler, a new Chronic [...]
Novartis ianalumab first drug to reduce disease activity and patient burden in Sjögren’s disease Phase III trials
29/10/2025
NEPTUNUS-1 and NEPTUNUS-2 achieved primary objective of reduced disease activity and provided clinically meaningful benefit 1 Data showed consistent improvements across secondary outcome measures, and a favorable safety [...]
MEDIROM to Launch New Treasury Strategy Utilizing Cryptocurrency
29/10/2025
Aimed at incentivize large-scale vital data collection TOKYO, Oct. 29, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc., (Headquarters: Minato-ku, Tokyo; President and CEO: Kouji Eguchi; listed on the [...]
OXB honoured at 2025 CDMO Leadership Awards Europe in ‘Cell & Gene Therapy’ category
29/10/2025
Oxford, UK – 29 October 2025: OXB (LSE: OXB), a global quality and innovation-led cell and gene therapy CDMO, today announces it has been recognised as a Champion in the ‘Cell & Gene Therapy’ category at the 2025 [...]
FDA Grants Orphan Drug Designation to Dewpoint Therapeutics’ DPTX3186 for the Treatment of Gastric Cancer
29/10/2025
First orphan designation ever granted to a condensate-modulating therapeutic Builds on recent IND opening for DPTX3186, a first-in-class oral condensate modulator targeting the Wnt/ β -catenin pathway Provides key [...]
Betterguards Launches The BetterGuard Lite, a Powerful New Ankle Protection System with Breakthrough Design
29/10/2025
The BetterGuard Lite features an impossibly thin, lightweight design at an affordable price for athletes worldwide NEW YORK, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Betterguards , a sports technology innovator, today [...]
Bioxytran Completes Randomized Clinical Trial For its Broad-Spectrum Antiviral Drug
29/10/2025
Data from the dose optimization trial expected soon ProLectin-M is positioned as the first oral antiviral sugar chemistry drug BOSTON, MASSACHUSETTS, Oct. 29, 2025 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTCQB: BIXT) (the [...]
Anaptys Announces New Positive Phase 2b Trial Results for Rosnilimab in Rheumatoid Arthritis at ACR Late-Breaking Oral Presentation
29/10/2025
New data reinforce rosnilimab’s efficacy profile in rheumatoid arthritis (RA) with deepening of clinical responses, including CDAI remission, from Week 12 to Week 28 regardless of prior advanced therapy, including JAKs [...]
MapLight Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
29/10/2025
SAN FRANCISCO and BOSTON, Oct. 29, 2025 (GLOBE NEWSWIRE) -- MapLight Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on improving the lives of patients suffering from debilitating central nervous [...]
Creative Medical Technology Holdings Announces Agreements for Exercise of Warrants for $4.2 Million Gross Proceeds
29/10/2025
PHOENIX, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc. , (Nasdaq: CELZ) (the “Company”), a clinical-stage biotechnology company pioneering regenerative immunotherapy, today announced that [...]
Lite Strategy Announces $25M Share Repurchase Program, Signaling Shift From Initial Litecoin Accumulation to Active Capital Market Operations
29/10/2025
LITS Board of Directors Reaffirms Commitment to Driving Long-Term Stockholder Value SAN DIEGO, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Lite Strategy, Inc. (NASDAQ: LITS) (“Lite Strategy” or “LITS”) today announced its Board [...]
National Survey Reveals Persistent Gaps in Pediatric Care Experiences Among U.S. Families
29/10/2025
Zarminali Pediatrics releases data emphasizing the need for more connected, coordinated care CHICAGO, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Zarminali Pediatrics , the first outpatient pediatric destination purpose-built to [...]
Vivian Health Partners with Hallmark to Power Faster, Smarter Hiring
29/10/2025
New integration connects Vivian, the largest healthcare talent marketplace, with Hallmark’s Workforce Intelligence and Enablement Platform—streamlining travel nurse and allied health clinician placements. SAN FRANCISCO [...]
Solana Company Announces Updated SOL Holdings and Industry Leading Staking Yield
29/10/2025
NEWTOWN, Pa., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Solana Company (NASDAQ: HSDT) (the “Company” or “HSDT”) today announced its updated Solana (“SOL”) token and cash holdings as of Oct. 29 at 12:00 am ET, as well as its [...]

Pages